Northern Trust Corp increased its holdings in DocGo Inc. (NASDAQ:DCGO – Free Report) by 24.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,606,139 shares of the company’s stock after buying an additional 320,133 shares during the period. Northern Trust Corp owned 1.57% of DocGo worth $6,810,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Invesco Ltd. lifted its holdings in shares of DocGo by 1.3% in the 4th quarter. Invesco Ltd. now owns 177,953 shares of the company’s stock worth $755,000 after acquiring an additional 2,312 shares during the last quarter. Summit Investment Advisors Inc. grew its position in DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after purchasing an additional 2,968 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of DocGo by 12.9% during the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after buying an additional 4,905 shares during the last quarter. Rhumbline Advisers boosted its stake in shares of DocGo by 4.5% in the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock worth $605,000 after buying an additional 6,204 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of DocGo by 12.3% during the 4th quarter. Victory Capital Management Inc. now owns 57,649 shares of the company’s stock worth $244,000 after acquiring an additional 6,300 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors.
DocGo Stock Performance
DCGO stock opened at $1.45 on Tuesday. The firm has a market cap of $147.88 million, a PE ratio of 5.18, a PEG ratio of 14.16 and a beta of 1.14. DocGo Inc. has a one year low of $1.35 and a one year high of $5.68. The firm’s 50 day moving average price is $2.33 and its 200-day moving average price is $3.60.
Analysts Set New Price Targets
Several research firms have recently commented on DCGO. Canaccord Genuity Group reissued a “hold” rating and issued a $1.45 target price (down previously from $5.00) on shares of DocGo in a report on Monday, May 12th. Needham & Company LLC dropped their price objective on DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a research report on Friday, May 9th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and dropped their price objective for the company from $5.00 to $2.85 in a report on Friday, February 28th. BTIG Research lowered DocGo from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Finally, Stifel Nicolaus decreased their price objective on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $3.56.
Read Our Latest Stock Report on DCGO
DocGo Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
- Five stocks we like better than DocGo
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- What Are Dividend Champions? How to Invest in the Champions
- What Ray Dalio’s Latest Moves Tell Investors
- How to Most Effectively Use the MarketBeat Earnings Screener
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.